XATMEP

Serial Number 86934766
Registration 5324671
702

Registration Progress

Application Filed
Mar 9, 2016
Under Examination
Sep 27, 2016
Approved for Publication
Aug 2, 2016
Published for Opposition
Aug 2, 2016
Registered
Oct 31, 2017

Trademark Image

XATMEP

Basic Information

Serial Number
86934766
Registration Number
5324671
Filing Date
March 9, 2016
Registration Date
October 31, 2017
Published for Opposition
August 2, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Mar 16, 2024
Registration
Registered
Classes
005

Rights Holder

AZURITY PHARMACEUTICALS, INC.

03
Address
8 CABOT ROAD, SUITE 2000
WOBURN, MA 01801

Ownership History

Argentum Holdings, LLC

Original Applicant
16
Palo Alto, CA

Argentum Holdings, LLC

Owner at Publication
16
Palo Alto, CA

Argentum Holdings, LLC

Original Registrant
16
Woburn, MA

AZURITY PHARMACEUTICALS, INC.

New Owner After Registration #1
03
WOBURN, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

Next Deadline
677 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20171031)
Due Date
October 31, 2027
Grace Period Ends
April 30, 2028

Application History

29 events
Date Code Type Description Documents
Jul 9, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 19, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 16, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Mar 16, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Mar 16, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 24, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 21, 2023 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Oct 31, 2022 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Oct 23, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 23, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 31, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 26, 2017 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 23, 2017 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 14, 2017 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 25, 2017 IUAF S USE AMENDMENT FILED Loading...
Sep 13, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 25, 2017 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 29, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 27, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 27, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 27, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 27, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 2, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 2, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 13, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 21, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 21, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 15, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 12, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders
First Use Anywhere: Jul 26, 2017
First Use in Commerce: Jul 26, 2017

Classification

International Classes
005